Table 1.

Distribution of immunotypes by clinical factors

Immunotype, n (%)
ABCPa
Total42 (28.6)93 (63.3)12 (8.2)
Cell type
 E28 (24.3)77 (67.0)10 (8.7)0.08
 M10 (47.6)11 (52.4)
 S4 (36.4)5 (45.5)2 (18.2)
Stage
 III28 (27.2)66 (64.1)9 (8.7)0.57
 IV14 (31.8)27 (61.4)3 (6.8)
Gender
 F17 (27.0)43 (68.3)3 (4.8)0.71
 M25 (29.8)50 (59.5)9 (10.7)
Tissue
 LN18 (25.0)47 (65.3)7 (9.7)0.35
 Peritoneum1 (100.0)
 Small bowel3 (50.0)3 (50.0)
 Skin/SQ21 (30.9)42 (61.8)5 (7.4)
Age
 <5014 (27.5)34 (66.7)3 (5.9)0.87
 ≥50 & <7015 (27.3)35 (63.6)5 (9.1)
 ≥7013 (31.7)24 (58.5)4 (9.8)
Prior vaccine
 N35 (28.7)78 (63.9)9 (7.4)0.94
 Y7 (28.0)15 (60.0)3 (12.0)
NED after surgery?
 N13 (35.1)23 (62.2)1 (2.7)0.31
 Y29 (26.4)70 (63.6)11 (10.0)
  • aχ2 test of association: A versus B+C.